Aminov Erez
- SEC CIK
- 0001986112
No open-market purchases or sales filed in the past year.
Current role at each company
- TELO Telomir Pharmaceuticals, Inc.CEO and Chairmanas of May 22, 2026
- MIRA Mira Pharmaceuticals, Inc.Chief Executive Officeras of Apr 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Aminov Erez as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MIRA Mira Pharmaceuticals, Inc.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 (view filing) | Nov 19-20 | 8 daysLate | Aminov ErezChief Executive Officer | SSale | −100.0K | $1.34 | −$133.6K | −8.6%1.06M after | 2 lots10b5-1 |
| May 22, 2024 (view filing) | May 21 | 1 day | Aminov ErezChief Executive Officer | PPurchase | +8.70K | $0.9398 | +$8.18K | +2.3%382.2K after | 8 lots |